We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.5M
AUM Growth
-$23M
Cap. Flow
-$2.06M
Cap. Flow %
-2.89%
Top 10 Hldgs %
68.62%
Holding
96
New
11
Increased
4
Reduced
26
Closed
18

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.13M
2
CVX icon
Chevron
CVX
+$2.64M
3
DVN icon
Devon Energy
DVN
+$2.48M
4
U icon
Unity
U
+$1.49M
5
ET icon
Energy Transfer Partners
ET
+$1.43M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.23M
2
ARWR icon
Arrowhead Research
ARWR
+$2.48M
3
SSYS icon
Stratasys
SSYS
+$1.74M
4
LNTH icon
Lantheus
LNTH
+$1.71M
5
AIRS icon
AirSculpt Technologies
AIRS
+$942K

Sector Composition

Rank Sector Weight
1 Healthcare 66.98%
2 Energy 21.36%
3 Technology 7.65%
4 Materials 1.27%
5 Communication Services 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMTX icon
51
Immatics
IMTX
$1.34B
$90K 0.13%
10,300
-27,200
-73% -$215K
CLRB icon
52
Cellectar Biosciences
CLRB
$20.1M
$88K 0.12%
725
– –
YCBD.PRA
53
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
$80K 0.11%
+22,000
New +$96.4K
SDPI
54
DELISTED
Superior Drilling Products Inc.
SDPI
$79K 0.11%
80,000
– –
CTSO icon
55
Cytosorbents Corp
CTSO
$24.2M
$77K 0.11%
35,000
– –
ATRA icon
56
Atara Biotherapeutics
ATRA
$76.9M
$72K 0.1%
368
– –
ENLV icon
57
Enlivex Ltd
ENLV
$36.7M
$68K 0.1%
1,000
-667
-40% -$51.7K
SEGG
58
Sports Entertainment Gaming Global Corp
SEGG
$8.64M
$63K 0.09%
40
– –
TCON
59
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$57K 0.08%
1,425
– –
YCBD icon
60
cbdMD
YCBD
$6.19M
$55K 0.08%
347
– –
YALA
61
Yalla Group
YALA
$815M
$53K 0.07%
13,500
– –
SIOX
62
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$53K 0.07%
146,500
– –
SQZ
63
DELISTED
SQZ Biotechnologies Company
SQZ
$51K 0.07%
16,000
– –
AMPE
64
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$49K 0.07%
972
– –
CYT
65
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$45K 0.06%
15,000
– –
PDSB icon
66
PDS Biotechnology
PDSB
$40.6M
$44K 0.06%
12,000
-48,000
-80% -$228K
HSDT icon
67
Solana Company
HSDT
$100M
$42K 0.06%
1
– –
OYST
68
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$37K 0.05%
8,500
-5,000
-37% -$28.4K
BLRX
69
BioLineRX
BLRX
$11.8M
$35K 0.05%
688
– –
SYRS
70
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$34K 0.05%
3,500
– –
LTRYW icon
71
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$785
$25K 0.04%
125,000
– –
TIL icon
72
Instil Bio
TIL
$49.2M
$23K 0.03%
250
-250
-50% -$35.4K
ARAV
73
DELISTED
Aravive, Inc. Common Stock
ARAV
$19K 0.03%
18,777
+1,277
+7% +$1.69K
ABTC
74
American Bitcoin Corp
ABTC
$477M
$18K 0.03%
4
– –
ORIO
75
Orion Digital Corp
ORIO
$15.6M
$17K 0.02%
6,497
-11,836
-65% -$56.3K
1 2
3
4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, ACT Capital Management held 96 positions worth $71.5M, down 24% from $94.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q2 2022 filing shows 11 new, 4 increased, 26 reduced and 18 closed positions. Its largest new stake was ExxonMobil: 56,900 shares worth $4.87M. The largest sale was NVIDIA, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 76% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q2 2022 buy was ExxonMobil: 56,900 shares worth $4.87M.
  • ACT Capital Management added most to Chevron in Q2 2022, an estimated $2.64M increase.
  • ACT Capital Management's biggest Q2 2022 reduction was Arrowhead Research, cutting an estimated $2.48M.
  • ACT Capital Management fully exited NVIDIA in Q2 2022, selling an estimated $4.23M.
  • ACT Capital Management's ten largest holdings make up 69% of its $71.5M portfolio in Q2 2022.
  • ACT Capital Management opened 11 new positions and closed 18 in Q2 2022.
  • ACT Capital Management's portfolio value fell 24% quarter-over-quarter to $71.5M.

Based on ACT Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.